AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed
--------------------------------------------------------------------
Source: CNBC
Published: 2026-03-27 23:54 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Europe, Economy & Finance, Financial Markets, Law & Courts, Drugs, Business & Economy, Crime & Justice
--------------------------------------------------------------------
Snippet:
AstraZeneca's stock jumped as much as 4% after Britain's most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials.
--------------------------------------------------------------------